Alphatec given an outperform rating by RBC

Alphatec Holdings, Inc. was rated at outperform, above average risk, by RBC Capital Markets analyst William R. Quirk. The company reported a solid second quarter, with upside to RBC's top and bottom line expectations. Alphatec's direct sales force increased to 31 reps, ahead of the analyst's estimate of 16. RBC remains aggressive buyers of the stock. Shares of the Carlsbad, Calif.-based medical device company were down 17 cents, or 3.08%, at $5.35 on volume of 96,013 shares versus the three-month running average of 63,721 shares. (Nasdaq: ATEC)

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.